Latest Cash Flow Reports News

Bod Science Limited reported a $576,000 net operating cash outflow for the September quarter, sustained by funding from Biortica Agrimed Limited under a Deed of Company Arrangement as it pursues a backdoor listing.

Energy Resources of Australia reported a $47.1 million cash outflow from operations and a $75.4 million investment spend in the September quarter, reducing cash reserves to $108.3 million.

Queste Communications reports steady investment holdings and a robust cash reserve of over $4 million for the quarter ending September 2025, underpinned by its controlling stake in Orion Equities.

Queste Communications Ltd reported a stable cash position with A$4.055 million in reserves at the end of September 2025, despite a slight net cash outflow from operations. The company’s financing activities provided a modest boost, underpinning its liquidity.

FBR Limited’s 2025 Annual Report reveals a substantial $54 million impairment charge that significantly worsens its financial results, pushing total losses to nearly $83 million. The adjustments highlight challenges in capitalised development and asset valuations amid ongoing robotics innovation.

Advance Metals Limited has responded to an ASX query clarifying its compliance with disclosure rules and marketing practices, while updating on its funding status and capital raise plans.

Dotz Nano has responded to an ASX price query following unusual trading activity, confirming no undisclosed information and reaffirming compliance with continuous disclosure rules.

Papyrus Australia reported a July 2025 cash flow update showing a stable cash position of AUD 303,000 and available funding supporting operations for over eight months. The company continues to manage its financing facilities prudently while navigating operational expenses.

Felix Group Holdings reported a 21% revenue increase in FY25, driven by strong enterprise platform sales and positive cash flow, while strategically acquiring Nexvia to expand its SaaS footprint in construction.

Nutritional Growth Solutions Ltd has clarified discrepancies in its June 2025 quarterly reports, attributing changes to timing and classification adjustments, while reaffirming its financial health and governance compliance.

HeraMED Limited has resumed trading on the ASX following the release of its quarterly reports and a significant capital raising announcement, marking a pivotal moment for the medical device company.

Syntara Limited’s trading suspension has been lifted as the company lodged its quarterly activity and cash flow reports for June 2025, reopening its shares to market activity.